NCT01923220View on ClinicalTrials.gov

Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Breast Cancer
Interventions
DRUG

HO/02/02 20µg

Interventions involving HO/02/02 20µg VS. Aloe Vera Jel (SOC). Treatment will be applied topically once daily

OTHER

Aloe Vera Jel

To be applied topically once daily

Trial Locations (1)

52621

The Chaim Sheba Medical Center, Ramat Gan

Sponsors

Lead Sponsor

HealOr
All Listed Sponsors
lead

HealOr

INDUSTRY

NCT01923220 - Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis | Biotech Hunter | Biotech Hunter